Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Norton

Showing results (81-90 of 293) with videos related to

Pageof 30
Sort By:
NPJ Breast Cancer|June 4, 2024
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancerNicholas Mai, Sara Myers, Sherry Shen, et al.
Scientific Reports|January 4, 2024
Dynamic network curvature analysis of gene expression reveals novel potential therapeutic targets in sarcomaRena Elkin, Jung Hun Oh, Filemon Dela Cruz, et al.
Drugs & Aging|September 15, 2005
Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancerArti Hurria, Anju Hurria, Kelly Brogan, et al.
Drugs & Aging|August 3, 2005
Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapyArti Hurria, Kelly Brogan, Katherine S Panageas, et al.
NPJ Breast Cancer|July 23, 2021
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinomaWillard Wong, Edi Brogi, Jorge S Reis-Filho, et al.
Breast Cancer Research and Treatment|April 28, 2012
Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulationYong Hannah Wen, Alice Ho, Sujata Patil, et al.
NPJ Breast Cancer|July 20, 2017
Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic reviewKaren A Cadoo, Devika Gajria, Emily Suh, et al.
Clinical Breast Cancer|September 1, 2006
A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancerShanu Modi, Gabriella D'Andrea, Larry Norton, et al.
Breast Cancer Research and Treatment|September 28, 2023
Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scoresAnne Grabenstetter, Edi Brogi, Donna M Thompson, et al.
NPJ Breast Cancer|August 11, 2022
Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapyAnne Grabenstetter, Edi Brogi, Hong Zhang, et al.
Pageof 30

Showing results (81-90 of 293) with videos related to

Sort By:
Pageof 30
NPJ Breast Cancer|June 4, 2024
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancerNicholas Mai, Sara Myers, Sherry Shen, et al.
Scientific Reports|January 4, 2024
Dynamic network curvature analysis of gene expression reveals novel potential therapeutic targets in sarcomaRena Elkin, Jung Hun Oh, Filemon Dela Cruz, et al.
Drugs & Aging|September 15, 2005
Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancerArti Hurria, Anju Hurria, Kelly Brogan, et al.
Drugs & Aging|August 3, 2005
Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapyArti Hurria, Kelly Brogan, Katherine S Panageas, et al.
NPJ Breast Cancer|July 23, 2021
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinomaWillard Wong, Edi Brogi, Jorge S Reis-Filho, et al.
Breast Cancer Research and Treatment|April 28, 2012
Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulationYong Hannah Wen, Alice Ho, Sujata Patil, et al.
NPJ Breast Cancer|July 20, 2017
Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic reviewKaren A Cadoo, Devika Gajria, Emily Suh, et al.
Clinical Breast Cancer|September 1, 2006
A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancerShanu Modi, Gabriella D'Andrea, Larry Norton, et al.
Breast Cancer Research and Treatment|September 28, 2023
Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scoresAnne Grabenstetter, Edi Brogi, Donna M Thompson, et al.
NPJ Breast Cancer|August 11, 2022
Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapyAnne Grabenstetter, Edi Brogi, Hong Zhang, et al.
Pageof 30